$MYGN
MYRIAD GENETICS INC

2012 Q3 Form 10-Q Financial Statement

#000119312512463615 Filed on November 09, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2011 Q3
Revenue $133.4M $110.5M
YoY Change 20.81% 20.19%
Cost Of Revenue $13.93M $11.30M
YoY Change 23.29% 2.73%
Gross Profit $119.5M $99.15M
YoY Change 20.53% 22.71%
Gross Profit Margin 89.56% 89.77%
Selling, General & Admin $56.13M $46.11M
YoY Change 21.72% 16.74%
% of Gross Profit 46.97% 46.51%
Research & Development $11.40M $8.505M
YoY Change 34.04% 46.64%
% of Gross Profit 9.54% 8.58%
Depreciation & Amortization $2.211M $2.147M
YoY Change 2.98% 19.28%
% of Gross Profit 1.85% 2.17%
Operating Expenses $67.53M $54.62M
YoY Change 23.63% 20.57%
Operating Profit $48.58M $41.47M
YoY Change 17.14% 16.82%
Interest Expense $1.400M $500.0K
YoY Change 180.0% -28.57%
% of Operating Profit 2.88% 1.21%
Other Income/Expense, Net $1.240M -$100.0K
YoY Change -1340.0% 0.0%
Pretax Income $49.82M $41.81M
YoY Change 19.18% 15.48%
Income Tax $19.69M $16.71M
% Of Pretax Income 39.51% 39.96%
Net Earnings $30.14M $25.10M
YoY Change 20.07% 11.55%
Net Earnings / Revenue 22.58% 22.72%
Basic Earnings Per Share $0.37 $0.29
Diluted Earnings Per Share $0.36 $0.29
COMMON SHARES
Basic Shares Outstanding 81.57M shares 85.24M shares
Diluted Shares Outstanding 83.91M shares 87.04M shares

Balance Sheet

Concept 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $349.2M $349.5M
YoY Change -0.09% -18.4%
Cash & Equivalents $95.58M $62.68M
Short-Term Investments $253.6M $286.8M
Other Short-Term Assets $10.90M $13.80M
YoY Change -21.01% -28.5%
Inventory $10.60M $9.700M
Prepaid Expenses $2.516M
Receivables $62.50M $44.80M
Other Receivables $2.000M $700.0K
Total Short-Term Assets $435.1M $418.5M
YoY Change 3.97% -14.9%
LONG-TERM ASSETS
Property, Plant & Equipment $24.76M $23.30M
YoY Change 6.25% -0.85%
Goodwill $56.85M
YoY Change
Intangibles $15.45M
YoY Change
Long-Term Investments $117.1M $52.20M
YoY Change 124.33% -34.83%
Other Assets $34.10M $35.50M
YoY Change -3.94% 164.93%
Total Long-Term Assets $267.9M $201.2M
YoY Change 33.16% 69.08%
TOTAL ASSETS
Total Short-Term Assets $435.1M $418.5M
Total Long-Term Assets $267.9M $201.2M
Total Assets $703.1M $619.7M
YoY Change 13.45% 1.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.09M $9.800M
YoY Change 13.12% 36.11%
Accrued Expenses $43.00M $20.40M
YoY Change 110.76% -13.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $57.36M $31.30M
YoY Change 83.25% 1.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.10M $9.400M
YoY Change 7.45% 6.82%
Total Long-Term Liabilities $10.10M $9.400M
YoY Change 7.45% 6.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.36M $31.30M
Total Long-Term Liabilities $10.10M $9.400M
Total Liabilities $67.49M $40.70M
YoY Change 65.83% 2.52%
SHAREHOLDERS EQUITY
Retained Earnings -$15.00M
YoY Change
Common Stock $814.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $635.6M $579.0M
YoY Change
Total Liabilities & Shareholders Equity $703.1M $619.7M
YoY Change 13.45% 1.46%

Cashflow Statement

Concept 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income $30.14M $25.10M
YoY Change 20.07% 11.55%
Depreciation, Depletion And Amortization $2.211M $2.147M
YoY Change 2.98% 19.28%
Cash From Operating Activities $51.36M $31.82M
YoY Change 61.38% 8.61%
INVESTING ACTIVITIES
Capital Expenditures -$2.500M -$2.100M
YoY Change 19.05% 5.0%
Acquisitions $799.0K
YoY Change
Other Investing Activities -$2.500M -$400.0K
YoY Change 525.0% -102.15%
Cash From Investing Activities -$5.005M -$2.532M
YoY Change 97.67% -115.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $46.20M $37.18M
YoY Change 24.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -37.12M -19.30M
YoY Change 92.36% 24.5%
NET CHANGE
Cash From Operating Activities 51.36M 31.82M
Cash From Investing Activities -5.005M -2.532M
Cash From Financing Activities -37.12M -19.30M
Net Change In Cash 9.231M 9.995M
YoY Change -7.64% -67.23%
FREE CASH FLOW
Cash From Operating Activities $51.36M $31.82M
Capital Expenditures -$2.500M -$2.100M
Free Cash Flow $53.86M $33.92M
YoY Change 58.75% 8.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52681000
CY2012Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10008000
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81403041 shares
CY2012Q2 us-gaap Other Assets
OtherAssets
8000000
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-162000
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44967000
CY2012Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2054000
CY2012Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
30648000
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12684000
CY2012Q2 us-gaap Assets
Assets
690635000
CY2012Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
420007000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86352000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.32
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60441000
CY2012Q2 us-gaap Inventory Net
InventoryNet
11574000
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4600000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15233281 shares
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72528000
CY2012Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
113692000
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1713000
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
690635000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82569000 shares
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
826000
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q2 us-gaap Goodwill
Goodwill
56850000
CY2012Q2 us-gaap Liabilities
Liabilities
54975000
CY2012Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
17800000
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15722000
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5572000
CY2012Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
54728000
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Other Assets
OtherAssets
8000000
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1350000
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
115583000
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32772000
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24231000
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82569000 shares
CY2012Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
254180000
CY2012Q2 us-gaap Assets Current
AssetsCurrent
422492000
CY2012Q2 us-gaap Other Receivables
OtherReceivables
2660000
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
647680000
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
48297000
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
635660000
CY2012Q2 us-gaap Notes Receivable Net
NotesReceivableNet
19000000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10141000
CY2011Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25000000
CY2011Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-123000
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62676000
CY2011Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2011Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-141000
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
208000
CY2012Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10138000
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
18.86
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
129000
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
57356000
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3275000
CY2012Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
26081000
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14997000
CY2012Q3 us-gaap Assets
Assets
703061000
CY2012Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
420483000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95583000
CY2012Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.07 pure
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.77
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62503000
CY2012Q3 us-gaap Inventory Net
InventoryNet
10602000
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
115774000
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17127609 shares
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
83000
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
75206000
CY2012Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
117125000
CY2012Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2516000
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
703061000
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81397000 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Goodwill
Goodwill
56850000
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
814000
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50449000
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
635567000
CY2012Q3 us-gaap Notes Receivable Net
NotesReceivableNet
19667000
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11086000
CY2012Q3 us-gaap Liabilities
Liabilities
67494000
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
253407000
CY2012Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
18054000
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15447000
CY2012Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8378000
CY2012Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
57152000
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42995000
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1500000
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24757000
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
253583000
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81397000 shares
CY2012Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
253582000
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
466073000
CY2012Q3 us-gaap Assets Current
AssetsCurrent
435134000
CY2012Q3 us-gaap Other Receivables
OtherReceivables
1970000
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
649621000
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 mygn Fair Value Option Loans Aggregate Principal Amount Outstanding
FairValueOptionLoansAggregatePrincipalAmountOutstanding
8000000
CY2012Q3 mygn Cash And Cash Equivalents And Available For Sale Securities Debt Maturities Estimated Fair Value
CashAndCashEquivalentsAndAvailableForSaleSecuritiesDebtMaturitiesEstimatedFairValue
466290000
CY2012Q3 mygn Residual Value Of Loan Agreement
ResidualValueOfLoanAgreement
17000000
CY2012Q3 mygn Accrued Value Of Loan Agreement
AccruedValueOfLoanAgreement
19667000
CY2010Q2 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
100000000
CY2010Q2 mygn Repurchase Program Date Authorized
RepurchaseProgramDateAuthorized
May 2010
CY2010Q2 mygn Repurchase Program Date Completed
RepurchaseProgramDateCompleted
August 2010
CY2010Q3 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
100000000
CY2010Q3 mygn Repurchase Program Date Authorized
RepurchaseProgramDateAuthorized
August 2010
CY2010Q3 mygn Repurchase Program Date Completed
RepurchaseProgramDateCompleted
February 2011
CY2011Q3 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
200000000
CY2011Q3 mygn Repurchase Program Date Authorized
RepurchaseProgramDateAuthorized
August 2011
CY2011Q3 mygn Repurchase Program Date Completed Description
RepurchaseProgramDateCompletedDescription
ongoing
CY2012Q3 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
200000000
CY2011Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
100000000
CY2011Q1 mygn Repurchase Program Date Authorized
RepurchaseProgramDateAuthorized
March 2011
CY2011Q1 mygn Repurchase Program Date Completed
RepurchaseProgramDateCompleted
September 2011
CY2011Q3 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
17000000
CY2011Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-14786000
CY2011Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2147000
CY2011Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
799000
CY2011Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2532000
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
473000
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8505000
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85241000 shares
CY2011Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
3061000
CY2011Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.40 pure
CY2011Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-245000
CY2011Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1150000
CY2011Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1684000 shares
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
41805000
CY2011Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
103969000
CY2011Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
25099000
CY2011Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4000
CY2011Q3 us-gaap Share Based Compensation
ShareBasedCompensation
6664000
CY2011Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4258000
CY2011Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9995000
CY2011Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
368000
CY2011Q3 us-gaap Other Operating Income
OtherOperatingIncome
333000
CY2011Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
6483000
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41472000
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2011Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1488000
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
25099000
CY2011Q3 us-gaap Costs And Expenses
CostsAndExpenses
68980000
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2011Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
37181000
CY2011Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
140000
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87037000 shares
CY2011Q3 us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
8000000
CY2011Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19297000
CY2011Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1796000 shares
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24835000
CY2011Q3 us-gaap Revenues
Revenues
110452000
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46114000
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16706000
CY2011Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
844000
CY2011Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2109000
CY2011Q3 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
17040000
CY2011Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
275000
CY2011Q3 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
41282000
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8490000 shares
CY2011Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
66658000
CY2011Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
79000
CY2011Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1473000
CY2011Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1576000
CY2011Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31824000
CY2011Q3 us-gaap Cost Of Revenue
CostOfRevenue
11300000
CY2011Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
7000
CY2011Q3 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
17040000
CY2011Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-140000
CY2011Q3 mygn Increase Decrease Operating Assets And Liabilities
IncreaseDecreaseOperatingAssetsAndLiabilities
CY2011Q3 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
24768000
CY2011Q3 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
12413000
CY2011Q3 mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
2147000
CY2012Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2012Q3 dei Document Type
DocumentType
10-Q
CY2012Q3 dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
CY2012Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000899923
CY2012Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2012Q3 dei Trading Symbol
TradingSymbol
MYGN
CY2012Q3 dei Entity Registrant Name
EntityRegistrantName
MYRIAD GENETICS INC
CY2012Q3 dei Amendment Flag
AmendmentFlag
false
CY2012Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2012Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2224000
CY2012Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
664075 shares
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2211000
CY2012Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5005000
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1368000
CY2012Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.98
CY2012Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11400000
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81572000 shares
CY2012Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
130000
CY2012Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
667000
CY2012Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
3395000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
136220 shares
CY2012Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.40 pure
CY2012Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1221000
CY2012Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9260000
CY2012Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1836000 shares
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
49822000
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
127268000
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
30136000
CY2012Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
6600000
CY2012Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
27.07
CY2012Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7195000
CY2012Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9231000
CY2012Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
803000
CY2012Q3 us-gaap Other Operating Income
OtherOperatingIncome
1240000
CY2012Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
53500000
CY2012Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
6169000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
48582000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2012Q3 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
500000000
CY2012Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-972000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
30136000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2694623 shares
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
84855000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2012Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46199000
CY2012Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
128000
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83914000 shares
CY2012Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37120000
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2342000 shares
CY2012Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30427000
CY2012Q3 us-gaap Revenues
Revenues
133437000
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56128000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19686000
CY2012Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8616000
CY2012Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2461000
CY2012Q3 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
463000
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
275000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
21.63
CY2012Q3 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
463000
CY2012Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-128000
CY2012Q3 mygn Increase Decrease Operating Assets And Liabilities
IncreaseDecreaseOperatingAssetsAndLiabilities
CY2012Q3 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
126903000
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3929000 shares
CY2012Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
124359000
CY2012Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-690000
CY2012Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10224000
CY2012Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
945000
CY2012Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51356000
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
13932000
CY2012Q3 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
32449000
CY2012Q3 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
13750000
CY2012Q3 mygn Income Related To Accretion Of Note Receivable And Stated Interest Rate
IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate
1098000
CY2012Q3 mygn Number Of Shares Transferred From One Stock Option Plan To Another
NumberOfSharesTransferredFromOneStockOptionPlanToAnother
9959000 shares
CY2012Q3 mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
2211000
CY2012Q3 mygn Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Option Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriodOptionVested
4 Y
CY2012Q3 mygn Share Based Compensation Arrangement By Share Based Payment Award Compensation Cost Net Of Tax
ShareBasedCompensationArrangementByShareBasedPaymentAwardCompensationCostNetOfTax
54962000
CY2012Q3 mygn Share Based Compensation Arrangement By Share Based Payment Award Options Expire From Date Of Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpireFromDateOfGrant
10 Y
CY2012Q3 mygn Share Based Compensation Arrangement Common Shares Eligible For Purchase Related To Options Vested And Exercisable Number
ShareBasedCompensationArrangementCommonSharesEligibleForPurchaseRelatedToOptionsVestedAndExercisableNumber
9106000 shares

Files In Submission

Name View Source Status
0001193125-12-463615-index-headers.html Edgar Link pending
0001193125-12-463615-index.html Edgar Link pending
0001193125-12-463615.txt Edgar Link pending
0001193125-12-463615-xbrl.zip Edgar Link pending
d404091d10q.htm Edgar Link pending
d404091dex311.htm Edgar Link pending
d404091dex312.htm Edgar Link pending
d404091dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
mygn-20120930.xml Edgar Link completed
mygn-20120930.xsd Edgar Link pending
mygn-20120930_cal.xml Edgar Link unprocessable
mygn-20120930_def.xml Edgar Link unprocessable
mygn-20120930_lab.xml Edgar Link unprocessable
mygn-20120930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending